Identification of cross-reactive superantigenic epitopes in Staphylococcal Enterotoxin B and Toxic Shock Syndrome toxin-1
Pang, L.T.Y.; Kum, W.W.W.; Kwok, A.Y.C.; Chow, A.W.
Journal of Investigative Medicine 47(2): 74A
1999
ISSN/ISBN: 1081-5589
Accession: 035074618
PDF emailed within 1 workday: $29.90
Related References
Kum, W.W.S.; Chow, A.W. 1998: Staphylococcal toxic shock syndrome toxin-1 and enterotoxin A share overlapping domains which are critical for superantigenic and lethal activities Journal of Investigative Medicine 46(3): 217AKum, W.W.; Chow, A.W. 2001: Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1 Journal of Infectious Diseases 183(12): 1739-1748
See, R.H.; Krystal, G.; Chow, A.W. 1990: Binding of toxic shock syndrome toxin 1 and staphylococcal enterotoxin a to separate epitopes on the hla dr receptor Clinical Research 38(1): 115A
De Boer, M.L.; Chow, A.W. 1994: Toxic shock syndrome toxin 1-producing Staphylococcus aureus isolates contain the staphylococcal enterotoxin B genetic element but do not express staphylococcal enterotoxin B Journal of Infectious Diseases 170(4): 818-827
Ferry, T.; Thomas, D.; Perpoint, T.; Lina, G.; Monneret, G.; Mohammedi, I.; Chidiac, C.; Peyramond, D.; Vandenesch, F.; Etienne, J. 2008: Analysis of superantigenic toxin Vp T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock Clinical Microbiology and Infection 14(6): 546-554
Shinagawa, K.; Suzuki, M.; Tanabayashi, K.; Konuma, H.; Matsusaka, N. 1987: Purification of staphylococcal toxic shock syndrome toxin 1 enterotoxin f and preparation of anti toxic shock syndrome toxin 1 serum Journal of the Faculty of Agriculture Iwate University 18(1): 47-58
Ferry, T.; Thomas, D.; Perpoint, T.; Lina, G.; Monneret, G.; Mohammedi, I.; Chidiac, C.; Peyramond, D.; Vandenesch, F.; Etienne, J. 2008: Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 14(6): 546-554
Kum, W.W.S.; Laupland, K.B.; Chow, A.W. 1993: Demonstration of lethal and superantigenic domains of staphylococcal toxic shock syndrome toxin-1 by monoclonal antibodies Clinical Research 41(1): 44A
De Boer, M.L.; Kum, W.W.; Chow, A.W. 1999: Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin a production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome Canadian Journal of Microbiology 45(3): 250-256
Nakagawa, S.; Kushiya, K.; Taneike, I.; Imanishi, K.'i.; Uchiyama, T.; Yamamoto, T. 2005: Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice Clinical and Diagnostic Laboratory Immunology 12(3): 399-408
Kum, W.W.; Laupland, K.B.; Chow, A.W. 2000: Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality Canadian Journal of Microbiology 46(2): 171-179
Lee, H.K.; Kim, J.-B.; Kim, H.; Jekarl, D.W.; Kim, Y.R.; Yu, J.K.; Park, Y.-J. 2014: Clonal spread of catalase-negative ST5/SCCmec Ii Staphylococcus aureus carrying the staphylococcal enterotoxin a (sea), staphylococcal enterotoxin b (seb), and toxic shock toxin (tst) virulence genes Annals of Clinical and Laboratory Science 44(4): 394-398
Schlievert, P.M. 1986: Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS Lancet 1(8490): 1149-1150
Pang, L.T.Y.; Chow, A.W. 1997: Relative role of toxic shock syndrome toxin-1 and staphylococcal enterotoxin A superantigens in the D-galactosamine-sensitized murine model of lethal shock Clinical and Investigative Medicine 20(4 Suppl): S56
Syverson, R.E. 1996: Inhibition of the production of staphylococcal toxic shock syndrome toxin-1 and enterotoxin B by surfactants Abstracts of the General Meeting of the American Society for Microbiology 96: 212
Schumacher-Perdreau, F.; Akatova, A.; Pulverer, G. 1995: Detection of staphylococcal enterotoxin B and toxic shock syndrome toxin: PCR versus conventional methods Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 282(4): 367-371
Scholl, P.R.; Diez, A.; Geha, R.S. 1989: Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules Journal of Immunology 143(8): 2583-2588
Schumacherperdreau, F.; Akatova, A.; Pulverer, G. 1995: Detection of staphylococcal enterotoxin B and toxic shock syndrome toxin : PCR versus conventioanl methods Zentralblatt für Bakteriologie 282(4): 367-371
See, R.H.; Krystal, G.; Chow, A.W. 1992: Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes Canadian Journal of Microbiology 38(9): 937-944
Becker, K.; Haverkämper, G.; von Eiff, C.; Roth, R.; Peters, G. 2001: Survey of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene in non-Staphylococcus aureus species European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 20(6): 407-409